CJ Healthcare established its presence in the pharmaceutical sector by acquiring Yugong Pharmaceutical in 1984 and later emerged as a specialized pharmaceutical firm within the CJ Group in April 2014. Apart from conducting our own research and development, we actively pursue CSV (shared value creation) management by engaging in collaborative open innovation with promising domestic and international venture companies to develop innovative and distinct medications. CJ Healthcare is committed to leading the future growth of the pharmaceutical industry and prioritizing the development of top-tier medications to evolve into a truly global pharmaceutical enterprise.
Products & Services
Amlodipine Adipate
Cefotiam Hydrochloride
Donepezil Hydrochloride
Irbesartan
Sites
CJ Healthcare
Country
South KoreaCity
Eumseong